Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

News > All

Total search results: 12301 | Ordered by Date (descending)
1 2 3 ... 122 123 124  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-USA.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-USA.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-USA.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
Calypso Biotech S.A.. (2/20/19). "Press Release: Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases". Amsterdam. 2019-02-20
MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. 2019-02-19
MDxHealth S.A.. (2/19/19). "Press Release: MDxHealth Appoints Michael K. McGarrity as CEO. Dr. Jan Groen Continues as an Advisor to the Board". Irvine, CA & Herstal. 2019-02-19
Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. 2019-02-15
InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena. 2019-02-14
AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. 2019-02-14
Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. 2019-02-14
Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA. 2019-02-13
TCR2 Therapeutics Inc.. (2/13/19). "Press Release: TCR2 Therapeutics Announces Pricing of Initial Public Offering of Common Stock". Cambridge, MA. 2019-02-13
Johnson & Johnson. (2/13/19). "Press Release: Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.". New Brunswick, NJ. 2019-02-13
Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel. 2019-02-13
Boehringer Ingelheim (Canada) Ltd.. (2/12/19). "Press Release: Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials". Burlington, ON & Markham, ON. 2019-02-12
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
Genedata AG. (2/12/19). "Press Release: Genedata Releases New Request Management System for Biotherapeutics R&D Processes". Basel. 2019-02-12
Evonik Industries AG. (2/12/19). "Press Release: Evonik more than Doubles Venture Capital to Accelerate Innovation. Evonik Has Launched Its Second Venture Capital Fund with a Volume of €150 Millionmillion". Essen. 2019-02-12
Bruker Corporation. (2/11/19). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results". Billerica, MA. 2019-02-11
Spectro Analytical Instruments GmbH. (2/11/19). "Press Release: Spectro Introduces SpectroGreen ICP-OES Analyzer". 2019-02-11
Bluebird Bio, Inc.. (2/11/19). "Press Release: Bluebird Bio Appoints Chip Baird as Chief Financial Officer". Cambridge, MA. 2019-02-11
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
Uniqure N.V.. (2/8/19). "Press Release: Uniqure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B". Lexington, MA & Amsterdam. 2019-02-08
Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". 2019-02-08
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases". South San Francisco, CA. 2019-02-07
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Co-marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations". South San Francisco, CA. 2019-02-07
Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona. 2019-02-07
HiberCell. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY. 2019-02-07
bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. 2019-02-07
Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. 2019-02-07
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results". South San Francisco, CA. 2019-02-07
Merck KGaA. (2/6/19). "Press Release: Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline". Darmstadt. 2019-02-06
MacroGenics, Inc.. (2/6/19). "Press Release: MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab". Rockville, MD. 2019-02-06
Andrew Alliance S.A.. (2/6/19). "Press Release: Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research". 2019-02-06
GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. 2019-02-06
Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2019-02-06
ProteoNic Biotechnology B.V.. (2/5/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company". Leiden. 2019-02-05
Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC. 2019-02-05
MorphoSys AG. (2/5/19). "Press Release: MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc.". Planegg. 2019-02-05
Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. 2019-02-05
Genedata AG. (2/4/19). "Press Release: New Web-based Genedata Screener Showcases at SLAS2019". Washington, DC. 2019-02-04
Sanofi S.A.. (2/4/19). "Press Release: CHMP Recommends Approval of Praluent (alirocumab) to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease". Paris & Tarrytown, NY. 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2018". Venlo. 2019-02-04
Avacta Group plc. (2/4/19). "Press Release: Moderna Exercises Option for an Exclusive Product License". 2019-02-04
Argen-X N.V. (Argenx). (2/4/19). "Press Release: Argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology". Breda, Ghent & San Diego, CA. 2019-02-04
[iito] Business Intelligence. (2/1/19). "Press Release: [iito] Web Portals Surpass Half a Million Page Views per Month". Bremen. 2019-02-01
Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. 2019-01-31
Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". 2019-01-31
Fluidigm Corporation. (1/31/19). "Press Release: Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1". South San Francisco, CA. 2019-01-31
MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. 2019-01-31
Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. 2019-01-31
MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. 2019-01-31
Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF". 2019-01-31
Beckman Coulter Life Sciences. (1/30/19). "Press Release: Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business". Indianapolis, IN. 2019-01-30
Orphazyme A/S. (1/30/19). "Press Release: Orphazyme Reports Positive Results from Full Data Set of Phase II/III Arimoclomol Tria in Niemann-Pick Disease Type C (NPC)". Copenhagen. 2019-01-30
Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA. 2019-01-30
Danaher Corporation. (1/29/19). "Press Release: Danaher Reports Fourth Quarter And Full Year 2018 Results". Washington, DC. 2019-01-29
Waters Corporation. (1/29/19). "Press Release: New Ion-Exchange Columns and Consumables Bring Flexibility, Reproducibility and Resolution to mAb Analysis". Milford, MA. 2019-01-29
MRM Proteomics Inc.. (1/28/19). "Press Release: MRM Proteomics and Biodesix Partner to Develop Precision Lung Cancer Diagnostics". Montréal, QC & Boulder, CO. 2019-01-28
Horizon Discovery Group plc. (1/28/19). "Press Release: Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology". Cambridge. 2019-01-28
Merck KGaA. (1/28/19). "Press Release: Boards of E. Merck KG Newly Elected. Incumbent Chairmen Re-elected". Darmstadt. 2019-01-28
Allogene Therapeutics, Inc.. (1/28/19). "Press Release: Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy". South San Francisco, CA & Paris. 2019-01-28
Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. 2019-01-26
MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. 2019-01-26
MaSTherCell Global, Inc.. (1/25/19). "Press Release: Great Point Partners-backed Strategic Partner MaSTherCell Global Announces Achievement of First Milestone Funding and Expansion with New Facility in Houston, Texas". Greenwich, CT & Houston, TX. 2019-01-25
Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Launches First Veterinary Vaccines Produced in China". Ingelheim. 2019-01-24
Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Partners with AMPATH to Scale Up Knowledge, Skills and Training for Healthcare Providers in Kenya". Ingelheim. 2019-01-24
Merck KGaA. (1/24/19). "Press Release: Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors [Not intended for UK- or US-based media]". Darmstadt. 2019-01-24
Waters Corporation. (1/23/19). "Press Release: Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full Year 2018 Financial Results". Milford, MA. 2019-01-23
Grifols S.A.. (1/23/19). "Press Release: Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals to Commercialize Fostamatinib in Europe". Barcelona. 2019-01-23
Sartorius AG. (1/23/19). "Press Release: Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)". Göttingen & Glasgow. 2019-01-23
Clariant International AG. (1/23/19). "Press Release: Clariant Partners with ExxonMobil and Renewable Energy Group to Advance Cellulosic Biofuel Research". Muttenz, Irving, TX & Ames, IA. 2019-01-23
Genmab A/S. (1/22/19). "Press Release: Genmab Announces Initiation of U.S. FDA Regulatory Submission for Label Expansion of Daratumumab in Combination with Lenalidomide and Dexamethasone in Front Line Multiple Myeloma". Copenhagen. 2019-01-22
Waters Corporation. (1/22/19). "Press Release: Waters Accelerates Biomedical Research with Faster, More Accurate Amino Acid Analysis". Milford, MA. 2019-01-22
Editas Medicine, Inc.. (1/22/19). "Press Release: Editas Medicine Announces Chief Executive Officer Transition. Katrine Bosley to Step Down as President and CEO". Cambridge, MA. 2019-01-22
Genmab A/S. (1/22/19). "Press Release: Genmab Announces 2018 Net Sales Figures for Darzalex (Daratumumab)". Copenhagen. 2019-01-22
GlaxoSmithKline plc. (1/22/19). "Press Release: GSK Completes Acquisition of Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2019-01-22
CRISPR Therapeutics AG. (1/22/19). "Press Release: CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies". Cambridge, MA, Boston, MA & Berlin. 2019-01-22
Uniqure N.V.. (1/22/19). "Press Release: Uniqure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntington’s Disease". Lexington, MA & Amsterdam. 2019-01-22
EBD Group. (1/22/19). "Press Release: Biotech Showcase Celebrates Record Attendance by Life Science Investors, CEOs". New York, NY, San Francisco, CA & Carlsbad, CA. 2019-01-22
Editas Medicine, Inc.. (1/21/19). "Press Release: Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101 to Treat Leber Congenital Amaurosis 10 (LCA10)". Cambridge, MA. 2019-01-21
Alnylam Pharmaceuticals, Inc.. (1/21/19). "Press Release: Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel". Zug & Petach Tikva. 2019-01-21
Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. 2019-01-21
Bruker Corporation. (1/18/19). "Press Release: Bruker Launches the G6 Leonardo for Oxygen, Nitrogen and Hydrogen (ONH) Analysis by Inert Gas Fusion". Delhi. 2019-01-18
Bavarian Nordic A/S. (1/18/19). "Press Release: Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN Smallpox Vaccine". Copenhagen. 2019-01-18
Aimmune Therapeutics, Inc.. (1/18/19). "Press Release: Aimmune Therapeutics Appoints Andrew Oxtoby as Chief Commercial Officer". Brisbane, CA. 2019-01-18
Stemline Therapeutics, Inc.. (1/18/19). "Press Release: Stemline Therapeutics Closes $92 Million Public Offering of Common Stock". New York, NY. 2019-01-18
MorphoSys AG. (1/17/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Expanded Clinical Development of Guselkumab (Tremfya) into Ulcerative Colitis". Planegg. 2019-01-17
Sanofi S.A.. (1/17/19). "Press Release: FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes". Paris & The Woodlands, TX. 2019-01-17
Qiagen N.V.. (1/16/19). "Press Release: Qiagen Receives Approval for EGFR Test in Lung Cancer as Companion Diagnostic in Japan". Hilden & Tokyo. 2019-01-16
Acceleron Pharma, Inc.. (1/16/19). "Press Release: Acceleron Announces Pricing of Public Offering of Common Stock". Cambridge, MA. 2019-01-16
Agilent Technologies Inc.. (1/16/19). "Press Release: Mala Anand to Join Agilent's Board of Directors". Santa Clara, CA. 2019-01-16
ADC Therapeutics S.A.. (1/16/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors". Lausanne. 2019-01-16
Inmune Bio, Inc.. (1/16/19). "Press Release: Inmune Bio, Inc. Announces Pricing of Initial Public Offering". Cambridge, MA. 2019-01-16
Merck KGaA. (1/16/19). "Press Release: Merck Welcomes Ten New Startups to Its Innovation Center". Darmstadt. 2019-01-16
Nanobiotix S.A.. (1/16/19). "Press Release: Nanobiotix Plans to Conduct Registered Public Offering in the United States". Paris & Cambridge, MA. 2019-01-16
Immunocore Ltd.. (1/15/19). "Press Release: Immunocore Names David Berman as Head of R&D". Oxford & Conshohocken, PA. 2019-01-15
Waters Corporation. (1/15/19). "Press Release: Waters Expands Accessibility to High Resolution MS Data with the First SmartMS-Enabled LC-MS Biopharma System". Milford, MA. 2019-01-15
Tecan Group Ltd.. (1/15/19). "Press Release: Achim von Leoprechting Promoted to Become CEO of Tecan after Retirement of David Martyr". Männedorf. 2019-01-15
Life Biosciences LLC. (1/15/19). "Press Release: Life Biosciences Announces Closing of $50 Million Series B Financing Round". Boston, MA. 2019-01-15
1 2 3 ... 122 123 124  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture BIO Deutschland German Biotech Days 2019 Würzburg 600x60px

» top